Summary: In the Netherlands 30% of all women of reproductive age are habitual smokers. One third of these women continue to smoke during pregnancy. Tobacco smoke consists of more than 3600 different compounds. One of its chief pharmacologically active ingredients is nicotine of which 60% is metabolized to cotinine. Cotinine is the best available biochemical marker of nicotine consumption because it is specific for tobacco smoke exposure and it has a relatively long mean t./ 2 of 15 hours. In the present study nicotine and cotinine concentrations were measured in 25 smoking and 25 non-smoking healthy pregnant women. In all 25 non-smoking pregnant women nicotine and cotinine levels were < 10mg/l. Light smokers (< 10 cigarettes/day) were found to have nicotine blood concentrations < 10mg/l and cotinine levels varying between 40 and 99 mg/1. Heavy smokers (^ 10 cigarettes/day) had nicotine concentrations < 10 mg/1, but high cotinine levels varying from 115 to 199 mg/1. Cotinine was also determined in 25 neonates of non-smoking mothers and in 34 neonates of smoking mothers. In 9 of these 34 newborns the relationship between maternal and neonatal cotinine concentrations was investigated. Cotinine levels in neonates born to non-smokers and to women who smoked less than 10 cigarettes/day were below the detection limit of 10 mg/1. Cotinine values in neonates whose mothers smoked ^ 10 cigarettes/day were significantly higher than in those whose mothers smoked < 10 cigarettes/day, but significantly lower than in their mothers. The results of this study confirm that cotinine is more useful than nicotine in discriminating non-smokers, light and heavy smokers. Cotinine concentrations were significantly lower in the neonates than in their mothers, but there was a strong positive linear relationship between maternal and neonatal cotinine concentrations.
Introduction
In the Netherlands 30% of all women of reproductive levels of carboxyhaemoglobin in fetal blood (8) . These age are habitual smokers. Surveys of smoking during effects are mainly caused by nicotine, tar and carbon pregnancy have shown that the prevalence of smoking monoxide. Nicotine also exerts significant haemodyin this group of women is high (1) . Several studies have namic effects in the mother by increasing arterial blood assessed that while approximately 40% of smokers may pressure and heart rate (9) . reduce their level of tobacco consumption during preg-_.-. A « . . . , , , ,..,",, σ r σ Fifty to ninety percent of nicotine m smoke is absorbed nancy, one third of all pregnant women continue t o , , ι j ^ j * j-i_^iji_i , _ _ N _ _. . , j . , -, by the smokers and can be detected in the blood shortly smoke (2, 3) . Nicotine dependence is the most powerful ;. .. /1AX . , . . .. . . , iri _ ' . . . \, ' , , , . , A . after smoking (10) . In adults the elimination half-life of driving force for continue the habit (4).
. . f, / . · * ι i™ · j nicotine in blood is approximately 120 minutes, and Tobacco smoke consists of more than 3600 different 60% of the substance is metabolized to cotinine (11, 12) , compounds (5) and its composition varies with the type of which 10 o /0 is excre ted as such in the urine (12) . Cotiof tobacco and the way it is smoked. The chief pharma-nine is slowly c i ea red from the body and is primarily cologically active ingredients are nicotine and tar. An eliminated by the liver (13) . Renal clearance accounts average cigarette contains approximately 1 mg nicotine. for ^0^ 17 ο /0 of total clearance. Because of the low Cigarette smoking during pregnancy is associated with rate of metabolism and renal excretion, the half-life (t/ 2 ) a well-documented increase in perinatal mortality and of cotinine is approximately 15 hours (10-20 h) (10) . morbidity rates (6, 7) . Most of the adverse effects of As a consequence of the long t./ 2 there is relatively little smoking are related to chronic fetal hypoxia arising fluctuation in blood concentration throughout the day. from decreased uteroplacental perfusion and increased Various biochemical procedures have been used to esti-mate exposure to tobacco smoke: blood concentrations of nicotine, cotinine, carbon monoxide (CO) carboxyhaemoglobin (COHb) and thiocyanate have been determined. Levels of thiocyanate, CO and COHb are easy to determine but may be artificially raised through exposures unrelated to smoking, such as traffic exhaust gases (CO) and diet (thiocyanate) (14) .
A few studies have attempted to compare the various biochemical tests. Hill et al. (15) concluded that plasma and serum cotinine are valid indicators of smoke absorption, while COHb levels correlate well with cigarette smoke inhalation. Pojer et al. (16) reached the same conclusion. Janns et al. (14) are of the opinion that measurements of cotinine are best used in discriminating smokers from non-smokers.
While the effects of nicotine on the pregnant mother and her fetus have already been discussed, little is known about the effects of cotinine. Benowitz et al. (11) observed no change in blood pressure, heart rate or skin temperature, effects extremely sensitive to low concentrations of nicotine. Keenan et al. (17) assessed that cotinine has psychoactive properties. Clark et al. (18) found that the pharmacodynamic activity of cotinine is only 1/100 of that of nicotine.
Even less is known about the effect of smoking on the actual concentrations of cotinine in smoking pregnant women and their newborns. For this purpose cotinine levels were measured simultaneously in maternal blood plasma (study group 1) and cord blood plasma (study group 2).
Subjects and Methods
Nicotine and cotinine concentrations were measured in the venous blood plasma of 25 smoking and 25 non-smoking healthy pregnant women, in the second trimester of their pregnancy. This checkpoint was chosen because Sexton et al. (19) indicated that by the time a smoker reaches her second trimester of pregnancy she will either stop smoking or will continue to smoke until delivery. A second study group consisted of 25 neonates born to non-smoking mothers and 34 neonates bom to smoking mothers. In 9 of these cases, the mothers were also investigated, in order to determine the relationship between maternal and neonatal cotinine concentrations. In the second group only cotinine levels were measured. Venous samples were taken because values for venous blood have been published and are available for comparison. Nicotine as well as cotinine levels were determined by gas chromatography (20) nitrogen-phosphorus detection of nicotine and cotinine. The measurements were conducted by the Department of Toxicology, University Hospital, Maastricht, The Netherlands. A Hewlett Packard 5890A gas Chromatograph was used. The detection limit for nicotine was 10 mg/1. Duplicity: nicotine 5.6%/cotinine 3.6%. Reproducibility: nicotine 8.4%/cotinine 5.3% The reference ranges for light smokers (< 10 cigarettes/day): nicotine < 10 mg/1/cotinine 10-100 mg/1 and heavy smokers (^ 10 cigarettes/day): nicotine > 10 mg/1/cotininê 100 mg/1, are mentioned in table 1.
Blood samples were drawn between 8.30 and 9.00 a.m., at least one hour after the last cigarette was smoked. Venous blood samples of the newborns were obtained from the clamped umbilical cord immediately after delivery. The samples of their mothers were drawn during labour, 2-5 hours after the last cigarette was smoked.
The Mann-Whiiney-U test was used to compare the differences between the cotinine concentrations in neonates born to smoking and non-smoking mothers.
The Wilcoxon signed rank test was used to test the significance of differences in the plasma cotinine concentration between smoking mothers and their newborns. The Spearman rank correlation coefficient was used to estimate the correlation between maternal and neonatal cotinine concentrations.
Results
In all 25 non-smoking pregnant women nicotine and cotinine levels were < 10 mg/1. The smoking group consisted of 13 women who reported smoking < 10 cigarettes/day (light smokers) and 12 women who reported smoking 10 or more cigarettes/day. The light smokers were found to have nicotine blood levels < 10 mg/1 and cotinine levels varying between 40 and 99 mg/1. Heavy smokers had nicotine levels < 10 mg/1, but high cotinine Cotinine levels in neonates of non-smokers and women who smoked less than 10 cigarettes/day were below the detection limit of 10 mg/L Figure 1 shows the cotinine concentrations in neonates in relation to their mothers' smoking habits. Cotinine values in neonates whose mothers smoked ^ 10 cigarettes/day were significantly higher (p < 0.001) than in those whose mothers smoked < 10 cigarettes/day, but significantly lower than in their mothers (p < 0.01). There seems to be a threshold around 10 cigarettes/day. The cotinine concentrations in the 9 smoking mothers and their infants are shown in table 2. The correlation between cotinine concentrations in maternal and umbilical vein plasma is illustrated in figure 2 . The Spearman rank correlation coefficient was 0.912 with a p-value of 0.001.
Discussion
The cotinine measurements in our first study group confirm that cotinine is more useful than nicotine for discriminating between non-smokers, light smokers and heavy smokers. This is in accordance with earlier findings (21) (22) (23) (24) (25) . Nicotine levels in smokers were below the detection limit of 10 mg/1 because blood samples were taken at least one hour after the last cigarette was smoked. In adults the elimination half-life of nicotine in blood is approximately 120 minutes. For comparison with other studies, it is important to state that none of the women in the present study underestimated their smoking habits.
The amount of products of tobacco smoke transmitted to the fetus varies consistently, depending on the proportion of each cigarette consumed, frequency of puffing, depth of inhalation and maternal metabolism (14, 15) . After birth, the neonate's own metabolism affects the levels and duration of exposure to smoke products. For this reason, cotinine measurements were carried out in the plasma of neonates born to smokers and non-smokers in parallel with measurements in maternal plasma.
The results of this study show that cotinine is easily transferred to the neonatal compartment. Cotinine concentrations were significantly lower in the neonates than in their mothers (p < 0.01), but there was a strong positive linear relationship between maternal and neonatal cotinine concentrations (r s = 0.912, p < 0.001). Donnenfeld et al. (26) found that fetal cotinine concentrations were about 90% of maternal values throughout gestation. Luck et al. (27) found similar cotinine concentrations in smoking mothers and their neonates.
Cotinine concentrations were below the detection limit of 10 mg/1 in neonates born to non-smoking mothers and in neonates born to mothers who smoked less than 10 cigarettes/day. Infants of mothers who smoked > 10 cigarettes/day had significantly higher cotinine levels (p < 0.001). There seems to be a threshold around 10 cigarettes/day.
Bardy et al. (28) measured tobacco exposure during pregnancy, in order to determine the effects on neonates of maternal smoking. They found a quantitative dose/ effect relationship between tobacco exposure (cotinine concentrations) and a decrease in the gestational age at birth and the size of the neonate. It might be fortuitous that Peacock et al. (29) found a threshold of 13 cigarettes per day for the effect of smoking on birth weight.
In conclusion, cotinine is more useful than nicotine for discriminating between non-smokers, light smokers and heavy smokers. Cotinine, the principal metabolite of nicotine, readily appears in measurable concentrations in the neonate when his/her mother smokes ^ 10 cigarettes per day. Cotinine concentrations in neonates are significantly lower than in their mothers, but there is a strong positive linear relationship between cotinine concentrations in the maternal and neonatal compartment. 
